Xiamen Amoytop Biotech Co Ltd (688278.SS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE100003RT3
Xiamen Amoytop Biotech Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 2.82 bn CNY | 3.70 bn CNY |
| Gross profit | 2.63 bn CNY | 3.70 bn CNY |
| Operating income | 970.74 m CNY | 1.25 bn CNY |
| EBIT | 931.67 m CNY | 1.18 bn CNY |
| Net income | 827.60 m CNY | 1.04 bn CNY |
| Diluted EPS – continuing operations | 2.03 CNY | 2.55 CNY |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Xiamen Amoytop Biotech Co Ltd
Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.
More stocks
- Trigano SA (TRI.PA)
- HMT(Xiamen)New Technical (603306.SS)
- Robotis Co.Ltd (108490.KQ)
- DYNEX CAPITAL INC (DX)
- PT Trimegah Bangun Persada Tbk (NCKL.JK)
- TAG Immobilien (TEG.DE)
- Micronics Japan Co Ltd (6871.T)
- Eclat Textile Co Ltd (1476.TW)
- Leroy Seafood Group ASA (LSG.OL)
- Liberty Global Ltd. (LBTYA)
- flatexDEGIRO (FTK.DE)
- BBVA Banco Frances SA ADR (BBAR)
Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.